Early onset of effect following galcanezumab treatment in patients with previous preventive medication failures
Todd J. Schwedt(Mayo Clinic in Arizona), Eric Pearlman(University of California, San Francisco), Laura Yunes‐Medina(Eli Lilly (United States)), Yanhong Dong(National University of Singapore), Katherine Standley, Dulanji Kuruppu(Eli Lilly (United States))
Cited by 28
Related Papers
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
|Nature Communications|2016|446